Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates.

Successful Medical Management of Life-threatening Hepatic Hemangioma in Neonates. Pediatrics Lekwuttikarn, R. n., Josephs, S. n., Teng, J. M. 2019

Abstract

Hepatic hemangioma (HH) is a common asymptomatic, self-limiting benign vascular tumor of the liver in neonates. Although complicated HHs are rare, they have significant risks of morbidity and mortality, especially during the perinatal period. Because of the high risks of complications from surgical interventions, there is an unmet need for effective medical therapy. We report 2 neonates with life-threatening HH who were evaluated for a liver transplant before being treated successfully with combined medical therapy, which included sirolimus, corticosteroids, and propranolol.

View details for DOI 10.1542/peds.2019-1339

View details for PubMedID 31511312